BB BIOTECH AG 13D and 13G filings for Myovant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:17 pm Sale |
2022-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB BIOTECH AG | 5,872,639 6.000% |
-249,400 (-4.07%) |
Filing |
| 2022-02-11 4:47 pm Purchase |
2021-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB BIOTECH AG | 6,122,039 6.600% |
1,365,000 (+28.69%) |
Filing |
| 2021-02-12 4:45 pm Sale |
2020-12-31 | 13G | Myovant Sciences Ltd. MYOV |
BB BIOTECH AG | 4,757,039 5.300% |
-58,070 (-1.21%) |
Filing |